Replies to post #135001 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Here is an interesting exercise. If one took the 32 psPD excluded from the trial, and then took 12 of the longest living indeterminate excluded from the trial -- that's 44 for those of us math challenged -- and put them in place of the last 44 enrolled in the trial, I'll make the bold prediction we would never have hit 248 PFS or 233 OS until at least 2019. (P.S. Celldex, OPtune and Celldex did not exclude those types of patients, imho.)